1. Home
  2. ACXP vs AERT Comparison

ACXP vs AERT Comparison

Compare ACXP & AERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • AERT
  • Stock Information
  • Founded
  • ACXP 2017
  • AERT 2012
  • Country
  • ACXP United States
  • AERT Singapore
  • Employees
  • ACXP N/A
  • AERT N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • AERT Professional Services
  • Sector
  • ACXP Health Care
  • AERT Consumer Discretionary
  • Exchange
  • ACXP Nasdaq
  • AERT Nasdaq
  • Market Cap
  • ACXP 8.4M
  • AERT 38.3M
  • IPO Year
  • ACXP 2021
  • AERT N/A
  • Fundamental
  • Price
  • ACXP $0.49
  • AERT $1.12
  • Analyst Decision
  • ACXP Strong Buy
  • AERT
  • Analyst Count
  • ACXP 2
  • AERT 0
  • Target Price
  • ACXP $10.00
  • AERT N/A
  • AVG Volume (30 Days)
  • ACXP 18.6M
  • AERT 325.1K
  • Earning Date
  • ACXP 08-08-2025
  • AERT 08-14-2025
  • Dividend Yield
  • ACXP N/A
  • AERT N/A
  • EPS Growth
  • ACXP N/A
  • AERT N/A
  • EPS
  • ACXP N/A
  • AERT N/A
  • Revenue
  • ACXP N/A
  • AERT $70,198,000.00
  • Revenue This Year
  • ACXP N/A
  • AERT N/A
  • Revenue Next Year
  • ACXP N/A
  • AERT N/A
  • P/E Ratio
  • ACXP N/A
  • AERT N/A
  • Revenue Growth
  • ACXP N/A
  • AERT 4.38
  • 52 Week Low
  • ACXP $0.30
  • AERT $0.46
  • 52 Week High
  • ACXP $3.33
  • AERT $2.93
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 51.70
  • AERT 61.21
  • Support Level
  • ACXP $0.46
  • AERT $0.90
  • Resistance Level
  • ACXP $0.56
  • AERT $1.37
  • Average True Range (ATR)
  • ACXP 0.10
  • AERT 0.23
  • MACD
  • ACXP -0.01
  • AERT 0.01
  • Stochastic Oscillator
  • ACXP 25.55
  • AERT 50.14

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

Share on Social Networks: